Litcius/Paper detail

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

Ilias Bensouna, Valérie Caudwell, Sabah Kubab, Sandra Acquaviva, Agathe Pardon, Nathalie Vittoz, Dogan-Firat Bozman, Latifa Hanafi, Anne‐Laure Faucon, P Housset

2021American Journal of Kidney Diseases136 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePeritoneal dialysisAntibody responseHemodialysisIntensive care medicineAntibodyDialysisImmunologyInternal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and Thrombosis
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis | Litcius